Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

680 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Neutrophil-to-lymphocyte ratio predicts early mortality in females with metastatic triple-negative breast cancer.
de la Cruz-Ku G, Chambergo-Michilot D, Torres-Roman JS, Rebaza P, Pinto J, Araujo J, Morante Z, Enriquez D, Flores C, Luque R, Saavedra A, Lujan M, Gomez H, Valcarcel B. de la Cruz-Ku G, et al. Among authors: luque r. PLoS One. 2020 Dec 7;15(12):e0243447. doi: 10.1371/journal.pone.0243447. eCollection 2020. PLoS One. 2020. PMID: 33284847 Free PMC article.
Breast-conserving surgery vs. total mastectomy in patients with triple negative breast cancer in early stages: A propensity score analysis.
De-la-Cruz-Ku G, Valcarcel B, Morante Z, Möller MG, Lizandro S, Rebaza LP, Enriquez D, Luque R, Luján-Peche MG, Eyzaguirre-Sandoval ME, Saavedra A, Razuri C, Pinto JA, Fuentes HA, Neciosup SP, Gomez HL. De-la-Cruz-Ku G, et al. Among authors: luque r. Breast Dis. 2020;39(1):29-35. doi: 10.3233/BD-190391. Breast Dis. 2020. PMID: 31903977
Lymph node ratio as best prognostic factor in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy.
De la Cruz-Ku GA, Chambergo-Michilot D, Valcarcel B, Rebaza P, Möller M, Araujo JM, Enriquez D, Morante Z, Razuri C, Luque R, Saavedra A, Eyzaguirre E, Lujan M, Noel N, Pinto J, Cotrina J, Gomez H. De la Cruz-Ku GA, et al. Among authors: luque r. Breast J. 2020 Sep;26(9):1659-1666. doi: 10.1111/tbj.13988. Epub 2020 Jul 25. Breast J. 2020. PMID: 32713113
Triple-negative breast cancer in Peru: 2000 patients and 15 years of experience.
De-la-Cruz-Ku G, Luyo M, Morante Z, Enriquez D, Möller MG, Chambergo-Michilot D, Flores L, Luque R, Saavedra A, Eyzaguirre-Sandoval ME, Luján-Peche MG, Noel N, Calderon H, Razuri C, Fuentes HA, Cotrina JM, Neciosup SP, Araujo J, Lema A, Pinto J, Gomez HL, Valcarcel B. De-la-Cruz-Ku G, et al. Among authors: luque r. PLoS One. 2020 Aug 24;15(8):e0237811. doi: 10.1371/journal.pone.0237811. eCollection 2020. PLoS One. 2020. PMID: 32833983 Free PMC article.
Brain Metastasis in Triple-Negative Breast Cancer.
Bustamante E, Casas F, Luque R, Piedra L, Barros-Sevillano S, Chambergo-Michilot D, Torres-Roman JS, Narvaez-Rojas A, Morante Z, Enriquez-Vera D, Desai A, Razuri C, De la Cruz-Ku G, Araujo J. Bustamante E, et al. Among authors: luque r. Breast J. 2024 Sep 30;2024:8816102. doi: 10.1155/2024/8816102. eCollection 2024. Breast J. 2024. PMID: 39742363 Free PMC article.
Differences in splicing factors may predict type 2 diabetes remission in the CORDIOPREV study.
Ojeda-Rodriguez A, Torres-Peña JD, Arenas-de Larriva AP, Rangel-Zuñiga OA, Podadera-Herreros A, Boughanem H, G-García ME, López-Moreno A, Katsiki N, Luque RM, Perez-Martinez P, Delgado-Lista J, Yubero-Serrano EM, Lopez-Miranda J. Ojeda-Rodriguez A, et al. Among authors: luque rm. iScience. 2024 Dec 4;28(1):111527. doi: 10.1016/j.isci.2024.111527. eCollection 2025 Jan 17. iScience. 2024. PMID: 39811651 Free PMC article.
Quantitative proteomic analysis unveils a critical role of VARS1 in hepatocellular carcinoma aggressiveness through the modulation of MAGI1 expression.
Hermán-Sánchez N, Del Rio-Moreno M, Ciria R, Sánchez-Frias ME, Fernández-Barrena MG, Uriarte I, Chicano-Galvez E, Ortea I, Peralbo-Molina Á, Briceño J, Avila MA, Rodríguez-Perálvarez M, Luque RM, López-Cánovas JL, Gahete MD. Hermán-Sánchez N, et al. Among authors: luque rm. Mol Cancer. 2025 Jan 14;24(1):15. doi: 10.1186/s12943-024-02206-5. Mol Cancer. 2025. PMID: 39810176 Free article.
Molecular Detection of Lymph Node Metastases with One-Step Nucleic Acid Amplification (OSNA) Pooling in Prostate Cancer: The POPCORN Study.
Cuadras M, Semidey ME, Planas J, de Torres IM, Regis L, Celma A, Trilla E, Ramón Y Cajal S, Medina RA, Congregado B, Marcilla D, Japón MA, Ramirez M, Calatrava-Fons A, Leivar A, Alonso MB, García E, González-Peramato P, Vazquez-Martul D, Concha-López Á, Chantada V, Queipo FJ, Gago JL, Carrato C, Luque RJ, Moreno-Jimenez J, Catalina-Fernández I, León C, Morote J. Cuadras M, et al. Among authors: luque rj. Int J Mol Sci. 2024 Dec 17;25(24):13489. doi: 10.3390/ijms252413489. Int J Mol Sci. 2024. PMID: 39769252 Free PMC article.
Clinical value of circulating splicing factors in prostate cancer: SRRM1 as a novel predictive biomarker and therapeutic target.
Montero-Hidalgo AJ, Gómez-Gómez E, Galán-Cañete M, Porcel-Pastrana F, Pérez-Gómez JM, Ortega-Bellido M, Carrasco-Valiente J, Chamorro-Castillo L, Campos-Hernández JP, Rangel-Zuñiga OA, González-Serrano T, Sánchez-Sánchez R, Sarmento-Cabral A, Gahete MD, Jiménez-Vacas JM, Luque RM. Montero-Hidalgo AJ, et al. Among authors: luque rm. Mol Ther Oncol. 2024 Nov 23;32(4):200910. doi: 10.1016/j.omton.2024.200910. eCollection 2024 Dec 19. Mol Ther Oncol. 2024. PMID: 39758250 Free PMC article.
680 results